4EASO can effectively down-regulate the expression of eIF4E protein in breast and prostate tumor xenografts (153), significantly inhibits tumor growth by binding to eIF4E mRNA, triggering RNA degradation mediated by RNA enzyme H (153). Here, EIF4E is linked to neoplasm.